Avita Medical, Inc.
http://avitamedical.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Avita Medical, Inc.
Tech Transfer Roundup: MD Anderson Inks Set Of IO Deals Covering US, UK, Japan, China
Three separate agreements team the innovative cancer research center with Takeda, Artios/ShangPharma, and Ziopharm. Hoth continues busy deal-making year by licensing gene therapy from North Carolina State.
Avita’s Recell Heals 98% Of Burns In Pediatric Trial
The Recell system of Spray-On Skin Cells combined with mesh autografts healed 98% of burns within four weeks in 23 pediatric patients treated under US FDA-approved compassionate use and continued access programs.
Deals Shaping The Medical Industry, November 2017
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2017.
Appointments: Astellas, MorphoSys, AZTherapies, Sigilon Therapeutics, Intec Pharma And Tenaya Therapeutics
This week's round-up includes promotions at Astellas, new CSOs at MorphoSys and Tenaya, a new president and CMO at AZTherapies, new directors at BioScience Managers, plus board changes at Intec and Sigilon.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Biomaterials
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Biotechnology
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
-
- Avita Group, Avita US